Kristin R Carner

Title: Kristin R Carner: Innovator in Lyme Disease Vaccines

Introduction

Kristin R Carner is a notable inventor based in San Diego, CA, who has made significant contributions to the field of immunology, particularly in the development of vaccines against Lyme Disease. With a total of 2 patents, her work focuses on innovative compositions and methods for administering Borrelia DNA.

Latest Patents

Kristin's latest patents include groundbreaking methods for creating vaccines against Lyme Disease. One patent discloses a vaccine containing a plasmid DNA encoding a promoter for driving expression in mammalian cells, along with DNA sequences for Borrelia OspA or OspB. This vaccine aims to elicit a protective immune response against Lyme Disease. Another patent details plasmid DNA encoding Borrelia genospecies antigens, which can be used to generate useful antibodies in hosts susceptible to Lyme Disease. These compositions are designed to facilitate an in vivo response, providing a promising avenue for Lyme Disease prevention.

Career Highlights

Throughout her career, Kristin has worked with reputable organizations such as Pasteur Merieux Serums Et Vaccins and Vical Incorporated. Her experience in these companies has allowed her to refine her expertise in vaccine development and immunological research.

Collaborations

Kristin has collaborated with esteemed colleagues, including Robert C Huebner and Jon A Norman, further enhancing her contributions to the field of immunology.

Conclusion

Kristin R Carner's innovative work in developing vaccines against Lyme Disease showcases her dedication to advancing medical science. Her patents reflect a commitment to creating effective solutions for public health challenges.